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Introduction
 Cancer directed therapies, over last few decades, 
have evolved significantly in spectrum, effectiveness, 
usage and safety. There is parallel improvement in cancer 
treatment outcome and management of therapy-related 
complications. In spite of these advancements, inpatient 
deaths in oncology centers are common occurrence with 
majority dying due to advanced disease. A considerable 
number of patients die during course of treatment and 
many of these deaths are related to cancer treatment. 
Nevertheless, the issue of death and dying has received 
limited attention within the context of patient management. 
A medical audit is an important tool to look into the trends 
of such deaths and it may also identify areas in need of 
improvement during patient care. In the United Kingdom, 
National Confidential Enquiry into Peri-operative Deaths 
is an organisation established in 1988 for audits in health 
1Department of Medical Oncology, 2Unit of Anesthesiology, 3Department of Surgical Oncology, 4Department of Radiation Oncology, 
B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India *For correspondence : drgp04@
gmail.com
Abstract
 Background: Little is known about mortality statistics of hospitalised cancer patients from developing 
countries. This paper describes the distribution of causes of death in various malignancies, status of malignancy at 
the time of death, type and intent of therapy received by the cancer patient prior to death and nature of infections 
in terminal cancer patients who died in hospital. We also aimed to study discrepancies in mortality reporting in 
terms of death certificate at our center and tried to analyse possible causes.  Results : Data for 259 consecutive 
deaths in hospitalized cancer patients in a calendar year were analysed. Of all these, 147 (57%) were cases of 
solid tumors, 107 (41%) were cases of hematological malignancies and 5 (2%) were other or undiagnosed cases. 
Median duration of hospital stay prior to death was 7 (1-106) days. Sepsis/multi organ dysfunction syndrome 
(MODS) was commonest immediate cause of death 118/259 (45.2%) followed by progressive malignancy in 
64/259 (24.7%) cases. Only 13/267 (5%) patients died with controlled cancer. Some 184 (71.3%) deaths occurred 
within 90 days of any form of anticancer treatment of which more than three fourths (77.2%) occurred after 
chemotherapy. Among these chemotherapy related deaths, 63 were febrile neutropenic deaths, with the commonest 
site of infection in the lungs, and positive blood culture was found in 18 (28%) cases. There were discrepancies 
in information derived from death certificates and from case records in 84 (32%) cases. Most of these were 
due to the use of ambiguous terms like cardio-respiratory arrest as a cause of death in the death certificate. 
Conclusion: It is important to audit mortality data on a regular basis as this can provide valuable insight into 
hospital practice and may help to identify preventable causes of mortality. Mortality record keeping is another 
important aspect as variable practices in this area may have implications for cancer mortality reporting and 
this may ultimately lead to erroneous cancer epidemiology. 
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care (O’Brien et al., 2006; Mort et al., 2008). Its spectrum 
has evolved from initial inclusion of only peri-operative 
deaths to presently medical as well as surgical deaths. 
Guidelines issued by the same have led to meaningful 
changes in healthcare practice as well. 
Large volume of published cancer mortality data 
is either in the form of clinical trial results or as an 
epidemiological account of mortality in an entire 
population. Specifically from oncology centers, focus has 
been on pattern of mortality in a particular cancer rather 
than on trends of inpatient mortality which is also a useful 
epidemiological parameter.
Mortality reporting discrepancies have been noted 
worldwide and cancer deaths are no exception (Moriyama 
et al., 1958; Steer et al., 1976). Use of ambiguous 
terminology in death certificates leads to erroneous 
mortality data of cancer patients. We audited the deaths 
of hospitalized patients in our center and present our 
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analysis which reflects hospital-based mortality pattern 
in oncology practice in a developing country. We also 
audited our death certificate in relation to primary cause 
of death mentioned by attending physician and inherent 
discrepancies in reporting. 
Materials and Methods
Our center is a referral oncology center with medical, 
radiation and surgical oncology along with palliative 
care services. All services regularly treat patients on 
inpatient basis. The inpatient deaths are recorded in a 
mortality register and the medical records of all deaths are 
maintained in record section. Approximately 8,000 new 
cancer patients are seen annually and common cancers 
are breast, lung, head and neck, cervix, prostate, leukemia 
and lymphomas.
Primary objective of this study was to study 
characteristics of deaths, ante-mortem therapies and their 
complications. Our secondary objective was to assess the 
discrepancies in reporting cause of death in cancer patients 
in death certificate at our center. 
Mortality records were retrieved for all inpatient 
deaths from 1st January 2008 to 31st December 2008. 
Source documents were hospital notes, nursing charts, 
and investigation reports. Along with demographic 
parameters we analysed type of therapy received by the 
patient (chemotherapy, radiotherapy, surgery, or stem cell 
transplant); lines of treatment (first or second/further lines 
of therapy); intent of treatment (curative or palliative); 
status of malignancy at time of death (controlled or 
uncontrolled disease); and causes of death with emphasis 
on neutropenic deaths. The cause of death was interpreted 
from the source documents, and the immediate cause of 
death was considered for analysis. Further we also noted 
the cause of death as recorded on the death certificate to 
see the discrepancies in mortality reporting.
Deaths occurring within 90 days of anticancer therapy 
were considered as mortality related to anticancer 
treatment. Status of cancer at the time of death, whether 
controlled or uncontrolled was recorded for all deaths. 
Controlled cancer in solid tumors was defined as clinical 
and radiological absence of disease for at least 1 month; 
for hematological malignancies, besides clinical and 
radiological response, hematological response was also 
considered to document the same. Non-responders 
and partial responders were grouped into uncontrolled 
malignancies.
Fever was defined as a single temperature of 38.3 ̊C 
or two temperature recordings greater than or equal to 38 
oC recorded at least four hours apart. Neutropenia was 
defined as absolute neutrophil count less than 1000/mm3 
with falling trend. Documented focus of infection was 
considered based on symptoms pertaining to a particular 
system with or without culture positivity in case of 
HEENT (head, ear, eyes, nose and throat), gastrointestinal 
tract, skin and subcutaneous tissue infections. Pneumonia 
was defined as fever with new infiltrate on a chest 
radiograph, and respiratory symptoms with or without an 
organism being isolated from sputum. Fungal pneumonia 
was defined on characteristic findings of high resolution 
CT scan of chest. For a documented blood or urinary tract 
infection, culture had to be positive. First line antibiotics 
were defined as antibiotics used for first episode of fever 
as per departmental policy. Any subsequent addition or 
replacement of antibiotics was taken as use of second 
line antibiotics. Use of antifungal agents was defined as 
systemic antifungal therapy in therapeutic doses with 
intent of treatment; patients who received antifungal 
agents for prophylaxis were not considered in the same 
group. 
Statistical analysis was carried out with SPSS 15.0 
(SPSS Inc., Chicago, IL, USA). This included descriptive 
analysis of demographic and clinical parameters. 
Table 1. Baseline Characteristics of the 259 Cases 
Median Age (Range) 46 years (2-83 years)
Male : Female 161:98
Type of Malignancies
• Solid Tumors 147 (57%)
• Hematological 
Malignancies
107 (41%)
• Others/Undiagnosed*     5  (2%)
Treating Departments
• Medical Oncology 126 (48.6%)
• Radiation Oncology 111 (42.8%)
• Surgical Oncology   10  (3.8%)
• Palliative Care Unit   12  (4.6%)
Age Group Distribution
• ≤14 years   19   (7%)
• 15-24   34  (13%)
• 25-34   29  (11%)
• 35-59 126  (49%)
• ≥60   51  (20%)
Last Anticancer Therapy 
(within 90 Days of Death) 
    N=184
• Chemotherapy 142  (77%)
• Radiotherapy   26 (14%)
• Surgery     9  (5%)
• Stem cell transplant     7  (4%)
Median Duration of Hospital 
Stay Prior to Death (Range)
7 days (1-106 days)
Median Duration from 
Therapy to Death (Range)
13 days (1-90 days)
 
*3 cases of undiagnosed malignancies, 1 case of severe 
combined immunodeficiency, and 1 case of disseminated 
tuberculosis (admitted with provisional diagnosis of lymphoma) 
Table 2. Profile of Deaths in Hematological Malignancies 
Versus Solid Tumors
Parameters Solid Hematological
(N= 147) (N= 107)
Status of Disease at Death
• Controlled   4 (2.7%) 9 (8.4%) 
• Uncontrolled 143(97.3%) 98(91.6%)
Intent of Therapy
• Curative 40 (27%) 71 (66%)
• Palliative 79 (54%) 21 (20%)
• Best Supportive Care Only 30 (20%) 15 (14%)
Curative Intent (N=40) (N=71)
• First Line of Therapy 38 (95%) 51 (70%)
• Second or Further Line  2  (5%) 22 (30%)
Palliative Intent (N=79) (N=21)
• First Line of Therapy 40 (51%)   5 (24%)
• Second or Further Line 39 (49%)  16 (76%)
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Categorical variables were summarised by frequency, 
and the quantitative variables were summarized by mean 
and standard deviation or median and range. Association 
for two-way tables, to assess difference between solid 
tumors and hematological malignancies was performed 
using the chi-square test. A P-value < 0.05 was considered 
significant. 
Results
Baseline Characteristics and Basic Demography
From January 2008 to December 2008, there were 
total 22,916 admissions; of which there were 18,311 
short admissions in day care facility, where no death was 
recorded. Of the 4605 admissions in the inpatient wards, 
there were 267 (5.8%) deaths in various departments. 
Data of 8 (3%) deaths was unavailable for analysis, and 
thus a total of 259 (97%) records were analyzed. The 
demographic parameters of these cases are shown in 
Table 1. Majority of deaths 126/259 (48.6%) were seen 
in age group 35-59 years. while 19/259 (7.3%) deaths 
were in pediatric age group and 51/259 (19.7%) in age 
group ≥60 years. 
Of 259 deaths, 184 (71%) deaths occurred within 90 
days of any form of anticancer treatment of which more 
than three-fourth (77%) occurred after chemotherapy. 
The status of malignancy was controlled in 4/147 (2.7%) 
deaths in solid tumors and 9/107 (8.4%) deaths in 
hematological malignancies (Table 2). Among all deaths, 
40/147 (27%) cases of solid tumor and 71/107 (66%) 
cases of hematological malignancies were treated with 
curative intent.
Forty five (17.3%) patients, who died, were on best 
supportive care due to their poor performance status. 
Twelve of these cases had curable malignancy and were 
admitted with intention of administering curative therapy, 
but they were initially given best supportive care only, due 
to their extremely poor general condition at admission, 
which precluded administration of anticancer therapy.
Etiology of Mortality
Sepsis/multi organ dysfunction swyndrome (MODS) 
emerged as most common immediate cause of death as 
observed in 118/259 (45%) cases followed by progressive 
malignancy in 64/259 (25%) cases (Table 3). Sepsis 
was the leading cause among those who died with 
hematological malignancies and gastrointestinal cancers. 
Likewise progressive malignancy was the leading cause of 
death amongst patients who died with carcinoma breast, 
carcinoma lung, and sarcomas. Neurological causes were 
present in 21/259 (8%) cases and they were seen primarily 
in cases of brain tumor or in those with brain metastasis. 
Severe hemorrhage was main cause of death in 18/259 
(7%) cases; majority of these being leukemia while 
amongst solid tumors massive bleeding was observed in 
head and neck cancer patients, in which 3/23 (13%) died 
of aspiration from torrential tumor bleed. 
Thirteen (5%) deaths were seen in cases with controlled 
malignancy of which 9 cases were hematological 
malignancies and 4 solid tumors. Amongst eight cases 
of acute leukemia who were in complete remission, four 
died of sepsis and one each died of intracranial bleeding, 
acanthameba meningitis, acute left ventricular failure and 
cardiac arrhythmia during central venous catheterisation. 
Amongst solid tumor cases who died in controlled 
malignancy state, the death was attributed to dengue 
hemorrhagic fever, radiation pneumonitis, pneumonia and 
septicemia in one case each.
Neutropenic deaths
Of 149 deaths within 90 days of chemotherapy or 
hematopoietic stem cell transplant (HSCT); 63 (42%) 
were neutropenic deaths. Amongst these cases, 44 (70%) 
Table 3. Distribution of Causes of Death with Various Malignancies
Cause of death Leukemia Lymphoma Myeloma Breast Lung H&N Gyn GIT Sarcomas Other Total (%)
Sepsis/MODS 45 20   6   5  4   9   5 16   3    5 118
(69%) (69%) (46%) (22%) (20%) (39%) (33%) (51%) (30%) (17%) (45%)
Progressive Disease   5   4   2 10 12   5   5 10   4   7   64
(8%) (14%) (15%) (44%) (55%) (20%) (33%) (32%) (40%) (24%) (25%)
Hemorrhage   8   2   1   1   1   3 - -   2   18 
(13%) (7%) (8%) (5%) (5%) (13%)  (7%) (7%)
Acute Renal Failure   1 -   2 -   2   1   1   1   2   10  
(4%)
Neurological causes*   3   1    1   2   1   3   1   1   1   7   21 
(8%)
Cardiac causes+   1 - - -   1 - -   1 -   2     5  
(2%)
Pulmonary causes# -   1   1 - - - - -   1   1     4 
(1.8%)
Others$   2 - -   1 - - -   1 -   1     5 
(2%)
Insufficient -   1 -   3   3   3   1   1   2   14 
    Information (5.4%)
Total (%) 65 29 13 22 22 23 15 31 10 29 259
(25%) (11%) (5%) (8%) (8%) (8.5%) (5.3%) (11%) (4%) (11%)
*Raised ICP/CVA/status epilepticus; +Arrhythmia/MI/CHF; #ARDS/bleomycin or radiation toxicity; $Dengue/DKA/SVCO/intestinal 
obstruction; ARDS, adult respiratory distress syndrome; CHF, congestive heart failure; CVA, cerebrovascular accidents;DKA, diabetic 
ketoacidosis; GIT, gastrointestinal tract malignancies; Gyn, gynecological malignancies, H&N, head and neck malignancies; ICP, 
intracranial pressure, MI, myocardial infarction, MODS, multiorgan dysfunction syndrome; SVCO, superior vena cava syndrome
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Table 4. Analysis of Febrile Neutropenic Deaths
Hematological 
(N=107)
Solid 
Tumors 
(N=147)
P 
value
Febrile neutropenic deaths 44 (41.5%) 19(12.9%) 0.04
  Detectable infection focus 37 (84%) 13  (69%) 0.158
• Lung 32 (72%)   8  (42%) 0.02
• Skin and subcutaneous   6(13.6%)   3(15.8%) 0.80
• Gastro-intestinal tract   2 (4.5%)   3(15.8%) 0.13
• Genito-urinary tract   1 (2.3%)   1 (5.3%) 0.53
• HEENT   2 (4.5%)   1 (5.3%) 0.9
• Blood   2 (4.5%)   1 (5.3%) 0.03
  No detectable focus   7 (16%)   6  (31%)
Microbiology pattern     (N=17)    (N=1)    -
• Escherichia coli    5 (29%)        -
• Klebsiella   5 (29%)   1(100%)
• Pseudomonas   3 (18%)         -
• MRSA   2 (12%)          - 
• Acenatobactor   2 (12%)         -
• Enterococcus   1  (6%)         -
• Salmonella   1  (6%)         -
Antibiotics First line only   7 (16%)   7 (37%) 0.06
Second line 37 (84%) 12 (63%)
Anti-fungal Used 31(70.5%)   5 (26%) 0.001
Not used 13(29.5%) 14 (74%)
Disease Controlled   3 (6.8%)   2(10.5%) 0.71
   status Uncontrolled 41(93.5%) 17(89.5%)
Abbreviations: HEENT- Head Eye Ear Nose and Throat, MRSA- 
Methicillin Resistant Staphylococcus aureus
deaths were in hematological malignancies and 19 (30%) 
in solid tumors. Documented infection was present in 
50/63 (80%) cases; 18/63 (29%) cases had a positive 
blood culture. Significantly higher number of septicemia 
and pneumonias were observed in the deaths occurring in 
hematological malignancies as compared to solid tumors 
(Table 4). Among 40 cases of pneumonia in neutropenic 
patients 8 (20%) were of fungal etiology and all these were 
patients of hematological malignancies. Use of second line 
of antibiotics and antifungal was also more frequent in 
hematological malignancies as compared to solid tumors.
Death certificate reporting
We noted that in 84/259 (32%) cases, cause of death 
could not be rightly assessed by death certificate alone. 
Amongst these 84 incomplete death certificate records, 
23 (27%) had a phrase like cardio-respiratory arrest or 
cardio-respiratory failure, while in 32 (38%) only the name 
of the malignancy was recorded. In rest of 29 cases cause 
of death recorded on death certificate did not match with 
the cause found after study of case records.
 
Discussion
This audit describes results of inpatient mortality in 
cancer patients from an oncology center from a developing 
country. In 13/254 (5%) cancer deaths, malignancy 
was in complete remission while in remaining 241/254 
(95%) cases disease was either uncontrolled or partially 
controlled. In latter group, there was active malignant 
disease present at the time of death which might have 
contributed in the death of patients. There was lack of 
sufficient data to clearly ascertain cause of death in 14 
cases; however none of these 14 deaths occurred in 
patients with complete remission. In a similar report from 
Royal Marsden Hospital, London, etiology of deaths 
in hospitalized patients of various malignancies within 
30 days of chemotherapy was primarily progression 
of underlying malignancy in 124/161 (77%) cases 
(O’Brien et al., 2006). Bouduer et al. from France 
reported progressive disease as primary cause of death 
in hospitalized patients in 56/81 (70%) cases (Bauduer 
et al., 2000). Terminal malignancy seems a logically 
correct most common cause of death in most cases but 
when it was studies in an autopsy series in a medical 
oncology center; cancer as a direct cause leading to 
death was found in only 9% of deaths. Most patients died 
of either sepsis or adult respiratory distress syndrome 
(Gerain et al., 1990). We also found that the sepsis was 
the commonest cause of death in 118/259 (45%) cancer 
patients. Similarly, a retrospective study of 267 elderly 
patients, with intermediate or high-grade Non-Hodgkin’s 
lymphoma receiving CHOP chemotherapy demonstrated 
a chemotherapy-related death rate of 13%. Infection 
accounted for 82% of these chemotherapy-related deaths 
(Gomez et al., 1998).
We believe that these differences in etiology of 
mortality are due to different practice of terminal care and 
mortality reporting at various centers across the world. At 
our centers majority of the admitted patients with advanced 
malignancies were administered palliative anticancer 
treatments. Treatment related neutropenia might have 
lead to higher incidence of sepsis and ultimately sepsis 
related death which is reflected in reporting of sepsis as 
a most common direct cause leading to death. However 
from palliative care units terminal malignancy is more 
likely to be reported as a direct cause of death.
We found that neutropenic deaths due to septicemia 
and pneumonia were significantly more in hematological 
malignancies as compared to solid tumors (Table 4). 
Worldwide, now with increasing use of indwelling 
catheters and chemotherapy ports, incidence of gram-
positive sepsis is increasing in neutropenic patients 
(Bullard and Dunn, 1996; Wolf et al., 2008). On the 
contrary we found that at our center 80% of the positive 
blood culture were gram-negative organisms, mainly 
Pseudomonas aeruginosa, Escherichia coli, and Klebsiella 
species. Amongst sites of documented infection, lung was 
the most common site in 40/63 (63.5%) cases; 8 of these 
were of fungal etiology and all these occurred in patients 
of hematological malignancies. This may be due to the 
fact that duration and severity of neutropenia is more in 
these patients and corticosteroids are common components 
of regimens for hematological malignancies, both of 
which predispose to increased risk of invasive fungal 
infection. Thus, the therapeutic use of antifungal agents 
was significantly more in hematological malignancies than 
in solid tumors (Table 4).
As compared to data from other center (O’Brien et al., 
2006), where most deaths occurred after second or third 
line of treatment, our analysis showed that maximum 
deaths occurred after first line of treatment, both in 
curative and palliative setting. This difference reflects 
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the pattern of presentation of malignancies in advanced 
stage in our setup. Similarly, 12/45 (26%) cases, who 
died on best supportive care were admitted for definitive 
anticancer treatment. However their poor performance 
status at the time of admission precluded administration 
of anticancer therapy. 
In the past, a number of authors have pointed out the 
inaccuracies of cancer death certificates by comparing the 
specified underlying cause of death to autopsy findings 
and to more specific hospital and pathologic information 
(Moriyama et al., 1958; Steer et al., 1976; Sington and 
Cottrell, 2002). Most of these studies dealt only with a 
small series of cases. In our analysis of data of 259 cases 
we found that 84/259 (32.4%) of death certificate were 
inconsistent with the likely cause of death. One reason of 
this variation can be differences in understanding of course 
of disease process among individual physicians. Another 
reason can be that more often than not, the physician 
attending patient at time of death and issuing death 
certificate was different from the main treating physician. 
Cardiac-arrest was used as cause of death mostly in cases 
who died following a course of advanced malignancy. 
Cardiac/respiratory failure was more often used as a 
generic term rather than a specific entity for congestive 
heart failure. Sington has reported discrepancies in cause 
of death mentioned on death certificate and the one found 
on necropsy in which the overall sensitivity of predicting 
correct cause of death from death certificate was 0.47, 
while sensitivity for all malignant causes of death was 
0.65 (Sington and Cottrell, 2002). The relevance of these 
discrepancies is that they may significantly alter mortality 
data, which can have a bearing on cancer epidemiology. 
Documentation of cause of death and diagnosis as per 
ICD-10 classification can help to bring in more uniformity 
in mortality reporting. 
At our canter 48.6% of deaths occurred in age group 
35-59 years which is much lesser than 19.7 % of deaths 
seen in patients more than 60 years of age. Median age 
at our center was 46 years (range 2-83 years). While 
O’Brien et al reports median age of inpatient cancer deaths 
at 61 years (range 6-86 years) (O’Brien et al., 2006). It 
will be erroneous to infer that cancer deaths occur more 
frequently in younger population in developing countries. 
Actually, this reflects the larger number of referral of 
younger patients to tertiary care hospital in our setup. 
Elderly patients with advanced malignancy are less likely 
to be referred for higher centers in a resource constrained 
population and most such patient die at home. 
A limitation of our study is that this is a single center 
data and mortality trend may be influenced by hospital 
admission policy. However this reflects current situation 
of cancer mortality from developing part of the world. In 
conclusions in the era of evidence based medicine and 
multi-center international research, we need to have more 
uniform ways of our record keeping and death reporting 
so that the comparisons can be more accurate. This study 
highlights the importance of medical audits, and their role 
is improving health care in the concerned hospital. A better 
knowledge of the profiles of dying patients in oncology 
departments is needed if we are to improve our approach 
in cancer epidemiology and management.
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